Complex Decongestive Therapy of Primary Lymphedema
Complex decongestive therapy (CDT) (also known as complete decongestive therapy or decongestive lymphatic therapy (DLT)) is now well established as the standard treatment for lymphedema regardless of the etiology (primary or secondary), its site (limb, trunk, or face), or its clinical stage . The best treatment protocol among whole CDT or single therapy (MLD, pneumatic pump, short-stretch bandages, compression garments, and therapeutic exercises) still could not be identified because of heterogeneity in the subject populations, measured outcomes, and follow-up durations in the current studies. Many studies have revealed the short-term and long-term benefits of CDT such as decreasing edema volume and improving quality of life (QOL) in patient with secondary lymphedema on limb [2, 3] or even head/neck area .
- 1.The diagnosis and treatment of peripheral lymphedema: 2013 consensus document of the international society of lymphology. Lymphology. 2013;46:1–11.Google Scholar
- 9.Foldi E, Foldi M. Complete decongestive therapy. In: Lee BB, Bergan J, Rockson SG, editors. Lymphedema; a concise compendium of theory and practice. London: Springer; 2011. p. 220–49.Google Scholar
- 10.Zuther JE. Lymphedema management: the comprehensive guide for practitioners. 2nd ed. New York: Thieme; 2009.Google Scholar
- 23.Lee H, Uhm KE, Hwang JH. Clinical characteristics and long-term outcomes in patients with primary lymphedema. In: Proceedings of 43rd annual meeting of the Korean Academy of Rehabilitation Medicine, Seoul; 2015.Google Scholar